<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 9.6.8042.36810 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 2/7/2022 11:04:21 AM -->
      <!-- iXBRL Library version: 1.0.8042.36816 -->
      <!-- iXBRL Service Job ID: 10a1f1a1-696c-46bd-a3a4-9d5902c86b66 -->

  <html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:gkos="http://www.glaukos.com/20220204" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" name="dei:EntityCentralIndexKey" id="Tc_y4VGHQ7bDkyWzSqg-uh8kA_2_1">0001192448</ix:nonNumeric><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" name="dei:AmendmentFlag" id="Tc_Wnrm07Xtkka3leN3gsZG5g_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="gkos-20220204.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001192448</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-04</xbrli:startDate><xbrli:endDate>2022-02-04</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:4.47%;padding-right:4.47%;position:relative;"><div style="clear:both;max-width:100%;position:relative;min-height:12.65pt;"><div style="padding-top:1.0px;border-top:3.0pt solid #000000;"><p style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.19;padding-top:1pt;text-align:center;border-top:1.0pt solid #000000;margin:0pt;"><b style="font-weight:bold;">\</b></p></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_5bc84378_ff63_473e_a352_9ee4a1f8a838"></a><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Washington, D.C. 20549</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:11.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:18pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM </b><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" name="dei:DocumentType" id="Narr_4EnHjDRJIUSZqxgsyFyf7w"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><div style="font-family:'Times New Roman','Times','serif';font-size:11.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Pursuant to Section&#160;13 or 15(d) of</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">The Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Date of Report (Date of earliest event reported):  </b><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_XPLAzjjGQk2H_xvBdIrtsA">February 4, 2022</ix:nonNumeric></p><div style="font-family:'Times New Roman','Times','serif';font-size:11.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:24pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" name="dei:EntityRegistrantName" id="Narr_N0gvKKwRZEyP_xamhuPYpA"><b style="font-weight:bold;">Glaukos Corporation</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Exact name of registrant as specified in its charter)</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:11.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_adf6efb8_e80d_4444_a11f_e012f477e899"></a><a id="Tc_wrFt98V0YUOSpeXpOl1I8Q_1_0"></a><a id="Tc_slSS2OdbRUqe7Z6YVeKxZA_1_2"></a><a id="Tc_ClKsyHTiTUuchgDh7c_5rA_1_4"></a><a id="Tc_R3wVoYYfNE-k_m1Snt97hA_2_0"></a><a id="Tc_a3EMT08ZoUyLxgzWWDve6g_2_2"></a><a id="Tc_A03qpkaUYkalQfgeTwN8Og_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:33.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0.8pt 0pt 0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_sy7dLewSLkmrSV3yQu-G-w_0_0"><b style="font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:30.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0.8pt 0pt 0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" name="dei:EntityFileNumber" id="Tc_jBUhd-uCNUOKR1d-W2Zb2Q_0_2"><b style="font-weight:bold;">001-37463</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:32.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0.8pt 0pt 0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" name="dei:EntityTaxIdentificationNumber" id="Tc_uWstZK2fhUqwM7nK5Vhazg_0_4"><b style="font-weight:bold;">33-0945406</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:33.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0.8pt 0pt 0pt;"><b style="font-weight:bold;">(State or other jurisdiction</b></p></td><td style="vertical-align:top;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:30.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0.8pt 0pt 0pt;"><b style="font-weight:bold;">(Commission</b></p></td><td style="vertical-align:bottom;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0.8pt 0pt 0pt;"><b style="font-weight:bold;">(I.R.S. Employer</b></p></td></tr><tr><td style="vertical-align:top;width:33.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0.8pt 0pt 0pt;"><b style="font-weight:bold;">of incorporation)</b></p></td><td style="vertical-align:top;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:30.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0.8pt 0pt 0pt;"><b style="font-weight:bold;">File Number)</b></p></td><td style="vertical-align:bottom;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0.8pt 0pt 0pt;"><b style="font-weight:bold;">Identification No.)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:4pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_7737ed79_5b51_49b9_8f27_209b8f61d8a5"></a><a id="Tc_hPzYc7wz30mT6JerelpW5A_0_0"></a><a id="Tc_BT81XaX2ME-_jEFQ4Ikuow_2_0"></a><a id="Tc_8Lkz7u2UK06Sr-0WOi_HsQ_2_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:49.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" name="dei:EntityAddressAddressLine1" id="Narr_Yy0jgEX7XEqfYLitafQR1g"><b style="font-weight:bold;">229 Avenida Fabricante</b></ix:nonNumeric><b style="font-weight:bold;"><br /></b><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" name="dei:EntityAddressCityOrTown" id="Narr_b5EAYcZXi0KGmtNwuONLWw"><b style="font-weight:bold;">San Clemente</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="Narr_yJZnUi7ES0m0Vh7B5Sb3cw"><b style="font-weight:bold;">California</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.44%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0.8pt 0pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:48.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0.8pt 0pt 0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" name="dei:EntityAddressPostalZipCode" id="Tc_m4nzYb5YREKBNq6aA34HfQ_0_2"><b style="font-weight:bold;">92672</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:49.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0.7pt 0pt 0pt;"><span style="font-size:3pt;font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0.7pt 0pt 0pt;"><span style="font-size:3pt;font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0.7pt 0pt 0pt;"><span style="font-size:3pt;font-weight:bold;margin-right:0pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:49.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0.7pt 0pt 0pt;"><b style="font-weight:bold;">(Address of principal executive offices)</b></p></td><td style="vertical-align:bottom;width:2.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0.7pt 0pt 0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:top;width:48.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0.7pt 0pt 0pt;"><b style="font-weight:bold;">(Zip Code)</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Registrant&#8217;s telephone number, including area code: (</b><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" name="dei:CityAreaCode" id="Narr_76zSG-t7bUG3AjKLXkEwfg"><b style="font-weight:bold;">949</b></ix:nonNumeric><b style="font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" name="dei:LocalPhoneNumber" id="Narr_vWB1qBrZtECHffxRvcdSeA"><b style="font-weight:bold;">367-9600</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Not Applicable</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">(Former name or former address, if changed since last report.)</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:11.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:8pt;margin-top:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_Pt5o4ieu-kGUt4LSQ4h_vA"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:8pt;margin-top:0pt;">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:8pt;margin-top:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_ABIb0TEHtkiehBfozgX6ug"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:8pt;margin-top:0pt;">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:8pt;margin-top:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_xp5N4W1aokO-GtMuCTMODg"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:8pt;margin-top:0pt;">Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:8pt;margin-top:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_WbTDzQaVH0ON__DU-k8ilQ"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:8pt;margin-top:0pt;">Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><a id="_a92f3e87_13e1_4f0d_9887_4170e05582ad"></a><a id="Tc_V1RjK_ySFkybc3b2fIJ0Og_1_0"></a><a id="Tc_cgi3iu-lwE-jcWEirbQ2sQ_1_2"></a><a id="Tc__qHwEJFGmUuqmKqlNEtNCQ_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:30.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:27.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:37.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:30.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><b style="font-weight:bold;">Title&#160;of&#160;each&#160;class:</b></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:27.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Trading Symbol</b></p></td><td style="vertical-align:bottom;width:1.98%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:37.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name&#160;of&#160;each&#160;exchange&#160;on&#160;which&#160;registered:</b></p></td></tr><tr><td style="vertical-align:top;width:30.79%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" name="dei:Security12bTitle" id="Tc_-p3WZuEOhUGy-kCBGG6bGA_2_0">Common Stock</ix:nonNumeric></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:27.83%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" name="dei:TradingSymbol" id="Tc_-34jUJEpaEimJoHwzrtc4g_2_2">GKOS</ix:nonNumeric></p></td><td style="vertical-align:bottom;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:37.38%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_bNUXP-v-90eoYqHwY5SS9w_2_4">New York Stock Exchange</ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#160;&#160;Emerging growth company&#160;<ix:nonNumeric contextRef="Duration_2_4_2022_To_2_4_2022_GgLX7oRfaUCcI9DFWSTFPw" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_KMxRYYMAtEadcs0IoWC7hg"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><a id="eolPage2"></a><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160; <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:4pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-weight:bold;line-height:1.19;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:91.06%;border:0;margin:30pt 4.47% 30pt 4.47%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_5886fc5a_4cc0_4e86_8ebf_8a5276fc1ab2"></a><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(b) On February 7, 2022, Glaukos Corporation (&#8220;Glaukos&#8221; or the &#8220;Company&#8221;) announced that Chris M. Calcaterra will step down from his role as the Company&#8217;s Chief Operating Officer and will transition to the position of EVP, Global Commercial Operations, effective April 1, 2022. Effective as of April 1, 2022, upon his appointment as EVP, Global Commercial Operations, Mr. Calcaterra will no longer be an &#8220;officer&#8221; of the Company under Rule 16a-1(f) or an &#8220;executive officer&#8221; of the Company under Rule 3b-7 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">(c) On February 7, 2022, the Company announced that Joseph E. Gilliam, the Company&#8217;s current Chief Financial Officer and Senior Vice President, Corporate Development, has been appointed as the Company&#8217;s President and Chief Operating Officer, which appointment will take effect on April 1, 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Mr. Gilliam, age 46, has served as the Company&#8217;s Chief Financial Officer and Senior Vice President, Corporate Development, since May 2017. From 2013 to May 2017, he was a managing director in the healthcare investment banking group at JPMorgan, where he also led the Glaukos initial public offering for the firm. From 2000 to 2013, Mr. Gilliam held increasingly responsible positions at JPMorgan and its predecessor organizations The Beacon Group and Chase Manhattan, with experience spanning mergers and acquisitions, primary and secondary public equity offerings, bank lending, bond offerings and other transactions. He started his career at PricewaterhouseCoopers  LLP. Mr. Gilliam currently serves on the board of directors and the audit committee of Caris Life Sciences. Mr. Gilliam has a B.S. in accounting from the Kelly School of Business at Indiana University.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">When this appointment becomes effective, Mr. Gilliam&#8217;s annual base salary will be increased to $505,000, and he will be eligible for an annual target bonus of 70% of his base salary, based upon achievement of certain Company and personal performance objectives. Additionally, in connection with his promotion to President and Chief Operating Officer, Mr. Gilliam will be entitled to receive a one-time, special promotion equity grant with a grant date value equal to $3,000,000, consisting of (i) 50% restricted stock units that will vest in two equal installments on the third and fourth anniversaries of the grant date and (ii) 50% performance-based options to purchase stock of the Company, with an exercise price equal to the closing market price on the date of grant, that will vest based on the achievement of annual revenue growth targets established for a four-year performance period. Mr. Gilliam is eligible to participate in the Company&#8217;s benefit plans that are available to executive officers of the Company generally.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Additionally, on February 7, 2022, the Company announced that Alex R. Thurman, the Company&#8217;s current Vice President, Finance, has been appointed as the Company&#8217;s Senior Vice President, Chief Financial Officer, which appointment will take effect on April 1, 2022. Effective as of April 1, 2022, Mr. Thurman will be designated an &#8220;officer&#8221; of the Company under Rule 16a-1(f) and an &#8220;executive officer&#8221; of the Company under Rule 3b-7 under the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">Mr. Thurman, age 52, has served as the Company&#8217;s Vice President, Finance since December 2016 and as its Vice President, Global Tax &amp; Administration from July 2016 to December 2016. Prior to that, Mr. Thurman held several roles of increasing responsibility at Allergan, Inc., including Director, U.S. Taxes; Director, Internal Audit; Senior Director, Corporate Accounting-Mergers &amp; Acquisitions, Business Development; and Senior Director, Finance &#8211; U.S. Facial Aesthetics Business from 2004 to 2016.  He began his career working at two public accounting firms:  Arthur Andersen LLP and Deloitte &amp; Touche LLP.  Mr. Thurman earned both his B.S. in Accounting and a Master of Accountancy in Tax from Brigham Young University.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">When this appointment becomes effective, Mr. Thurman&#8217;s annual base salary will be increased to $365,000, and he will be eligible for an annual target bonus of 50% of his base salary, based upon achievement of </p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">certain Company and personal performance objectives. Mr. Thurman is eligible to participate in the Company&#8217;s benefit plans that are available to executive officers of the Company generally.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">In connection with his appointment, Mr. Thurman will enter into an Executive Severance and Change in Control Agreement (&#8220;Severance Agreement&#8221;) with the Company, to be effective on April 1, 2022.  Pursuant to the terms of the Severance Agreement, if Mr. Thurman is terminated as a result of (i) an involuntary termination without &#8220;cause&#8221; or (ii) a resignation for &#8220;good reason&#8221; (each as defined in the Severance Agreement), then he will receive an amount equal to 12 months of his base salary amount in effect at the time of such termination. Mr. Thurman will also vest in all equity and equity-based awards that would otherwise have vested during the 12 months following the date of such termination. If Mr. Thurman is terminated as a result of (i) an involuntary termination without cause or (ii) a resignation for good reason, in either case within three months prior or 12 months following a &#8220;change in control&#8221; (as defined in the Severance Agreement), then he will receive an amount equal to the sum of (i) 18 months of his base salary amount in effect at the time of such termination, and (ii) 1.5 times his target annual bonus for the year in which the change in control occurs. Mr. Thurman will also vest in all equity and equity-based awards outstanding on the date of termination. In the event of any such termination, Mr. Thurman (and his spouse and dependents) will also receive medical and dental benefits provided by the Company at least equal to the levels of benefits provided to our similarly situated active employees for up to 12 months (or 18 months for a qualifying termination in connection with a change in control). All of the above benefits are subject to the executive&#8217;s execution of a general release of claims in the Company&#8217;s favor. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Mr. Thurman will also enter into the Company&#8217;s standard form of Indemnification Agreement, which was filed as Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 5, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_cf6f3ebf_f3d5_4c19_bd9c_8d86e2638629"></a><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Item 7.01. Regulation FD Disclosure.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">The press release issued by the Company announcing the appointments of Messrs. Gilliam and Thurman is attached to this Current Report on Form 8-K as Exhibit 99.1.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. This information shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Item 9.01. Financial Statements and Exhibits.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">(d) <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibits</span>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:12.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:84.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:12.91%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Exhibit No.</b></p></td><td style="vertical-align:bottom;width:2.35%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:84.72%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:bottom;width:12.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">99.1</p></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:84.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="gkos-20220204xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Press Release of Glaukos Corporation, dated February 7, 2022</span></a>.</p></td></tr><tr><td style="vertical-align:bottom;width:12.91%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">104</p></td><td style="vertical-align:bottom;width:2.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:84.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:bold;margin-bottom:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_5debd805_8dae_4a25_a6eb_11984d0747a2"></a><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SIGNATURE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr><td style="vertical-align:bottom;width:49.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p></td><td colspan="2" style="vertical-align:bottom;width:50.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">GLAUKOS CORPORATION</b><br /><i style="font-style:italic;">(Registrant)</i> &#160;</p></td></tr><tr><td style="vertical-align:bottom;width:49.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:50.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:4.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:46.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;/s/ Thomas W. Burns</p></td></tr><tr><td style="vertical-align:bottom;width:49.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:4.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:46.09%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">Name:&#160;&#160;&#160;&#160;&#160;Thomas W. Burns</p></td></tr><tr><td style="vertical-align:bottom;width:49.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:4.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:46.09%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:43.2pt;text-indent:-43.2pt;margin:0pt;">Title:&#160;&#160;&#160;&#160;&#160;&#160;&#160;President and Chief Executive Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">Date: February 7, 2022</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-weight:bold;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "gkos-20220204x8k.htm", "description": "8-K", "secsgml_size_bytes": 47777}]
{"company-data": {"conformed-name": "GLAUKOS Corp", "cik": "0001192448", "assigned-sic": "3841", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-37463", "film-number": "22597624"}, "business-address": {"street1": "229 AVENIDA FABRICANTE", "city": "SAN CLEMENTE", "state": "CA", "zip": "92672", "phone": "949-367-9600"}, "mail-address": {"street1": "229 AVENIDA FABRICANTE", "city": "SAN CLEMENTE", "state": "CA", "zip": "92672"}, "former-company": {"former-conformed-name": "GLAUKOS CORP", "date-changed": "20020925"}}
\
​
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
​
CURRENT REPORT
​
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
​
Date of Report (Date of earliest event reported):
February 4, 2022
Glaukos Corporation
(Exact name of registrant as specified in its charter)
​
Delaware
001-37463
33-0945406
(State or other jurisdiction
​
(Commission
​
(I.R.S. Employer
of incorporation)
​
File Number)
​
Identification No.)
​
​
229 Avenida Fabricante
San Clemente
,
California
92672
​
​
​
(Address of principal executive offices)
(Zip Code)
​
Registrant's telephone number, including area code: (
949
)
367-9600
​
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class:
Trading Symbol
Name of each exchange on which registered:
Common Stock
​
GKOS
​
New York Stock Exchange
​
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).  Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
​
​
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
(b) On February 7, 2022, Glaukos Corporation ("Glaukos" or the "Company") announced that Chris M. Calcaterra will step down from his role as the Company's Chief Operating Officer and will transition to the position of EVP, Global Commercial Operations, effective April 1, 2022. Effective as of April 1, 2022, upon his appointment as EVP, Global Commercial Operations, Mr. Calcaterra will no longer be an "officer" of the Company under Rule 16a-1(f) or an "executive officer" of the Company under Rule 3b-7 under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
(c) On February 7, 2022, the Company announced that Joseph E. Gilliam, the Company's current Chief Financial Officer and Senior Vice President, Corporate Development, has been appointed as the Company's President and Chief Operating Officer, which appointment will take effect on April 1, 2022.
Mr. Gilliam, age 46, has served as the Company's Chief Financial Officer and Senior Vice President, Corporate Development, since May 2017. From 2013 to May 2017, he was a managing director in the healthcare investment banking group at JPMorgan, where he also led the Glaukos initial public offering for the firm. From 2000 to 2013, Mr. Gilliam held increasingly responsible positions at JPMorgan and its predecessor organizations The Beacon Group and Chase Manhattan, with experience spanning mergers and acquisitions, primary and secondary public equity offerings, bank lending, bond offerings and other transactions. He started his career at PricewaterhouseCoopers  LLP. Mr. Gilliam currently serves on the board of directors and the audit committee of Caris Life Sciences. Mr. Gilliam has a B.S. in accounting from the Kelly School of Business at Indiana University.
When this appointment becomes effective, Mr. Gilliam's annual base salary will be increased to $505,000, and he will be eligible for an annual target bonus of 70% of his base salary, based upon achievement of certain Company and personal performance objectives. Additionally, in connection with his promotion to President and Chief Operating Officer, Mr. Gilliam will be entitled to receive a one-time, special promotion equity grant with a grant date value equal to $3,000,000, consisting of (i) 50% restricted stock units that will vest in two equal installments on the third and fourth anniversaries of the grant date and (ii) 50% performance-based options to purchase stock of the Company, with an exercise price equal to the closing market price on the date of grant, that will vest based on the achievement of annual revenue growth targets established for a four-year performance period. Mr. Gilliam is eligible to participate in the Company's benefit plans that are available to executive officers of the Company generally.
Additionally, on February 7, 2022, the Company announced that Alex R. Thurman, the Company's current Vice President, Finance, has been appointed as the Company's Senior Vice President, Chief Financial Officer, which appointment will take effect on April 1, 2022. Effective as of April 1, 2022, Mr. Thurman will be designated an "officer" of the Company under Rule 16a-1(f) and an "executive officer" of the Company under Rule 3b-7 under the Exchange Act.
Mr. Thurman, age 52, has served as the Company's Vice President, Finance since December 2016 and as its Vice President, Global Tax & Administration from July 2016 to December 2016. Prior to that, Mr. Thurman held several roles of increasing responsibility at Allergan, Inc., including Director, U.S. Taxes; Director, Internal Audit; Senior Director, Corporate Accounting-Mergers & Acquisitions, Business Development; and Senior Director, Finance – U.S. Facial Aesthetics Business from 2004 to 2016.  He began his career working at two public accounting firms:  Arthur Andersen LLP and Deloitte & Touche LLP.  Mr. Thurman earned both his B.S. in Accounting and a Master of Accountancy in Tax from Brigham Young University.
When this appointment becomes effective, Mr. Thurman's annual base salary will be increased to $365,000, and he will be eligible for an annual target bonus of 50% of his base salary, based upon achievement of
certain Company and personal performance objectives. Mr. Thurman is eligible to participate in the Company's benefit plans that are available to executive officers of the Company generally.
In connection with his appointment, Mr. Thurman will enter into an Executive Severance and Change in Control Agreement ("Severance Agreement") with the Company, to be effective on April 1, 2022.  Pursuant to the terms of the Severance Agreement, if Mr. Thurman is terminated as a result of (i) an involuntary termination without "cause" or (ii) a resignation for "good reason" (each as defined in the Severance Agreement), then he will receive an amount equal to 12 months of his base salary amount in effect at the time of such termination. Mr. Thurman will also vest in all equity and equity-based awards that would otherwise have vested during the 12 months following the date of such termination. If Mr. Thurman is terminated as a result of (i) an involuntary termination without cause or (ii) a resignation for good reason, in either case within three months prior or 12 months following a "change in control" (as defined in the Severance Agreement), then he will receive an amount equal to the sum of (i) 18 months of his base salary amount in effect at the time of such termination, and (ii) 1.5 times his target annual bonus for the year in which the change in control occurs. Mr. Thurman will also vest in all equity and equity-based awards outstanding on the date of termination. In the event of any such termination, Mr. Thurman (and his spouse and dependents) will also receive medical and dental benefits provided by the Company at least equal to the levels of benefits provided to our similarly situated active employees for up to 12 months (or 18 months for a qualifying termination in connection with a change in control). All of the above benefits are subject to the executive's execution of a general release of claims in the Company's favor.
Mr. Thurman will also enter into the Company's standard form of Indemnification Agreement, which was filed as Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 5, 2021.
​
Item 7.01. Regulation FD Disclosure.
The press release issued by the Company announcing the appointments of Messrs. Gilliam and Thurman is attached to this Current Report on Form 8-K as Exhibit 99.1.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
​
Item 9.01. Financial Statements and Exhibits.
​
(d)
Exhibits
.
​
​
​
​
Exhibit No.
Description
99.1
Press Release of Glaukos Corporation, dated February 7, 2022
.
104
​
Cover Page Interactive Data File (embedded within the Inline XBRL document)
​
​
​
​
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GLAUKOS CORPORATION
(Registrant)
​
​
By:
/s/ Thomas W. Burns
Name:     Thomas W. Burns
Title:       President and Chief Executive Officer
​
Date: February 7, 2022
​
​